Loading…

T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma

T2-weighted MRI shows potential in early posttreatment assessment of the primary tumor. Residual masses composed entirely of low T2-signal scar tissue suggest local control and those ≥1 cm of similar signal to untreated tumor suggest local failure. The purpose of this study was to investigate the di...

Full description

Saved in:
Bibliographic Details
Published in:American journal of neuroradiology : AJNR 2013-06, Vol.34 (6), p.1237-1241
Main Authors: King, A D, Keung, C K, Yu, K-H, Mo, F K F, Bhatia, K S, Yeung, D K W, Tse, G M K, Vlantis, A C, Ahuja, A T
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3
cites cdi_FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3
container_end_page 1241
container_issue 6
container_start_page 1237
container_title American journal of neuroradiology : AJNR
container_volume 34
creator King, A D
Keung, C K
Yu, K-H
Mo, F K F
Bhatia, K S
Yeung, D K W
Tse, G M K
Vlantis, A C
Ahuja, A T
description T2-weighted MRI shows potential in early posttreatment assessment of the primary tumor. Residual masses composed entirely of low T2-signal scar tissue suggest local control and those ≥1 cm of similar signal to untreated tumor suggest local failure. The purpose of this study was to investigate the diagnostic accuracy of T2-weighted MR imaging early after chemoradiotherapy for identifying primary tumor treatment failure in squamous cell carcinoma of the head and neck. At 6 weeks after treatment, T2-weighted MR images of 37 primary tumors in 37 patients were assessed. Residual masses were divided into 3 patterns: pattern 1 = scar tissue only (flat-edged/retracted mass of low T2 signal intensity); pattern 2 = mass without features described in pattern 1 or 3; and pattern 3 = any pattern that included an expansile mass ≥1 cm of intermediate T2 signal intensity (similar grade of signal intensity to the untreated tumor). T2 patterns were analyzed for local outcome (Fisher exact test) and time to local failure (univariate and multivariate analysis of T2 pattern, age, T stage, and tumor size by use of the Cox regression model). Residual masses after treatment were present in 34 (92%) of 37 patients. Local failures occurred in residual masses with pattern 1 in 0 (0%) of 14 patients; pattern 2 in 6 (55%) of 11 patients; and pattern 3 in 9 (100%) of 9 patients. Significant associations were found between local control and pattern 1 (P =
doi_str_mv 10.3174/ajnr.A3378
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7964595</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1367877893</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3</originalsourceid><addsrcrecordid>eNqFkU-LFDEQxYMo7rh68QNIjiL0mnSS7uQiLIv_YEWQFbyF6nT1dNbuZDZJrwz44e1x1kVPQkEd6ser93iEPOfsTPBWvobrkM7OhWj1A7LhRjSVUebbQ7Jh3Kiq4UyfkCc5XzPGlGnrx-SkFoI1jNcb8vOqrn6g344Fe_rpC_UzbH3YUoQ07SkMBRN1I84xQe9jGTHBbk9LpHgL0wIFaUkIZcZQaMK8iyEj9YGOCD2F0NOA7jvNNwvMccnU4TRRB8n5EGd4Sh4NMGV8drdPydd3b68uPlSXn99_vDi_rJzkvFTc9cY47EwjWa8GkFob1zfSdRrW0VI4aBSCG3Q9CFGzruGD7rpeKslk58QpeXPU3S3djL1bzSaY7C6tadPeRvD230vwo93GW9uuL5VRq8DLO4EUbxbMxc4-H7JAwDWW5UrxppbaiP-joml12x7RV0fUpZhzwuHeEWf20Kw9NGt_N7vCL_7OcI_-qVL8Alekoyk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1367877893</pqid></control><display><type>article</type><title>T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma</title><source>NCBI_PubMed Central(免费)</source><creator>King, A D ; Keung, C K ; Yu, K-H ; Mo, F K F ; Bhatia, K S ; Yeung, D K W ; Tse, G M K ; Vlantis, A C ; Ahuja, A T</creator><creatorcontrib>King, A D ; Keung, C K ; Yu, K-H ; Mo, F K F ; Bhatia, K S ; Yeung, D K W ; Tse, G M K ; Vlantis, A C ; Ahuja, A T</creatorcontrib><description>T2-weighted MRI shows potential in early posttreatment assessment of the primary tumor. Residual masses composed entirely of low T2-signal scar tissue suggest local control and those ≥1 cm of similar signal to untreated tumor suggest local failure. The purpose of this study was to investigate the diagnostic accuracy of T2-weighted MR imaging early after chemoradiotherapy for identifying primary tumor treatment failure in squamous cell carcinoma of the head and neck. At 6 weeks after treatment, T2-weighted MR images of 37 primary tumors in 37 patients were assessed. Residual masses were divided into 3 patterns: pattern 1 = scar tissue only (flat-edged/retracted mass of low T2 signal intensity); pattern 2 = mass without features described in pattern 1 or 3; and pattern 3 = any pattern that included an expansile mass ≥1 cm of intermediate T2 signal intensity (similar grade of signal intensity to the untreated tumor). T2 patterns were analyzed for local outcome (Fisher exact test) and time to local failure (univariate and multivariate analysis of T2 pattern, age, T stage, and tumor size by use of the Cox regression model). Residual masses after treatment were present in 34 (92%) of 37 patients. Local failures occurred in residual masses with pattern 1 in 0 (0%) of 14 patients; pattern 2 in 6 (55%) of 11 patients; and pattern 3 in 9 (100%) of 9 patients. Significant associations were found between local control and pattern 1 (P = &lt;.0001; sensitivity, 74%; specificity, 100%; PPV, 100%; NPV, 75%; accuracy, 85%), and between local failure and pattern 3 (P = &lt;.0001; sensitivity, 60%; specificity, 100%; PPV, 100%; NPV, 76%; accuracy, 82%). Pattern 2 showed no significant associations with local outcome. Univariate analysis of time to local failure showed that the T2 pattern was significant (P &lt; .0001) and remained significant on multivariate analysis. T2-weighted MR imaging is a potential tool for early posttreatment assessment of primary HNSCC treatment response. Awareness of correlation of the T2 pattern of any residual mass with treatment outcome at the primary site may contribute to patient treatment.</description><identifier>ISSN: 0195-6108</identifier><identifier>EISSN: 1936-959X</identifier><identifier>DOI: 10.3174/ajnr.A3378</identifier><identifier>PMID: 23306012</identifier><language>eng</language><publisher>United States: American Society of Neuroradiology</publisher><subject>Aged ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - therapy ; Chemoradiotherapy ; Diffusion Magnetic Resonance Imaging - methods ; Diffusion Magnetic Resonance Imaging - standards ; Drug Monitoring - methods ; Female ; Head &amp; Neck ; Head and Neck Neoplasms - pathology ; Head and Neck Neoplasms - therapy ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm, Residual - pathology ; Neoplasm, Residual - therapy ; Nuclear polyhedrosis virus ; Predictive Value of Tests ; Reproducibility of Results ; Retrospective Studies ; Sensitivity and Specificity ; Treatment Failure</subject><ispartof>American journal of neuroradiology : AJNR, 2013-06, Vol.34 (6), p.1237-1241</ispartof><rights>2013 by American Journal of Neuroradiology 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3</citedby><cites>FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7964595/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7964595/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23306012$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>King, A D</creatorcontrib><creatorcontrib>Keung, C K</creatorcontrib><creatorcontrib>Yu, K-H</creatorcontrib><creatorcontrib>Mo, F K F</creatorcontrib><creatorcontrib>Bhatia, K S</creatorcontrib><creatorcontrib>Yeung, D K W</creatorcontrib><creatorcontrib>Tse, G M K</creatorcontrib><creatorcontrib>Vlantis, A C</creatorcontrib><creatorcontrib>Ahuja, A T</creatorcontrib><title>T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma</title><title>American journal of neuroradiology : AJNR</title><addtitle>AJNR Am J Neuroradiol</addtitle><description>T2-weighted MRI shows potential in early posttreatment assessment of the primary tumor. Residual masses composed entirely of low T2-signal scar tissue suggest local control and those ≥1 cm of similar signal to untreated tumor suggest local failure. The purpose of this study was to investigate the diagnostic accuracy of T2-weighted MR imaging early after chemoradiotherapy for identifying primary tumor treatment failure in squamous cell carcinoma of the head and neck. At 6 weeks after treatment, T2-weighted MR images of 37 primary tumors in 37 patients were assessed. Residual masses were divided into 3 patterns: pattern 1 = scar tissue only (flat-edged/retracted mass of low T2 signal intensity); pattern 2 = mass without features described in pattern 1 or 3; and pattern 3 = any pattern that included an expansile mass ≥1 cm of intermediate T2 signal intensity (similar grade of signal intensity to the untreated tumor). T2 patterns were analyzed for local outcome (Fisher exact test) and time to local failure (univariate and multivariate analysis of T2 pattern, age, T stage, and tumor size by use of the Cox regression model). Residual masses after treatment were present in 34 (92%) of 37 patients. Local failures occurred in residual masses with pattern 1 in 0 (0%) of 14 patients; pattern 2 in 6 (55%) of 11 patients; and pattern 3 in 9 (100%) of 9 patients. Significant associations were found between local control and pattern 1 (P = &lt;.0001; sensitivity, 74%; specificity, 100%; PPV, 100%; NPV, 75%; accuracy, 85%), and between local failure and pattern 3 (P = &lt;.0001; sensitivity, 60%; specificity, 100%; PPV, 100%; NPV, 76%; accuracy, 82%). Pattern 2 showed no significant associations with local outcome. Univariate analysis of time to local failure showed that the T2 pattern was significant (P &lt; .0001) and remained significant on multivariate analysis. T2-weighted MR imaging is a potential tool for early posttreatment assessment of primary HNSCC treatment response. Awareness of correlation of the T2 pattern of any residual mass with treatment outcome at the primary site may contribute to patient treatment.</description><subject>Aged</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - therapy</subject><subject>Chemoradiotherapy</subject><subject>Diffusion Magnetic Resonance Imaging - methods</subject><subject>Diffusion Magnetic Resonance Imaging - standards</subject><subject>Drug Monitoring - methods</subject><subject>Female</subject><subject>Head &amp; Neck</subject><subject>Head and Neck Neoplasms - pathology</subject><subject>Head and Neck Neoplasms - therapy</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm, Residual - pathology</subject><subject>Neoplasm, Residual - therapy</subject><subject>Nuclear polyhedrosis virus</subject><subject>Predictive Value of Tests</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Sensitivity and Specificity</subject><subject>Treatment Failure</subject><issn>0195-6108</issn><issn>1936-959X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFkU-LFDEQxYMo7rh68QNIjiL0mnSS7uQiLIv_YEWQFbyF6nT1dNbuZDZJrwz44e1x1kVPQkEd6ser93iEPOfsTPBWvobrkM7OhWj1A7LhRjSVUebbQ7Jh3Kiq4UyfkCc5XzPGlGnrx-SkFoI1jNcb8vOqrn6g344Fe_rpC_UzbH3YUoQ07SkMBRN1I84xQe9jGTHBbk9LpHgL0wIFaUkIZcZQaMK8iyEj9YGOCD2F0NOA7jvNNwvMccnU4TRRB8n5EGd4Sh4NMGV8drdPydd3b68uPlSXn99_vDi_rJzkvFTc9cY47EwjWa8GkFob1zfSdRrW0VI4aBSCG3Q9CFGzruGD7rpeKslk58QpeXPU3S3djL1bzSaY7C6tadPeRvD230vwo93GW9uuL5VRq8DLO4EUbxbMxc4-H7JAwDWW5UrxppbaiP-joml12x7RV0fUpZhzwuHeEWf20Kw9NGt_N7vCL_7OcI_-qVL8Alekoyk</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>King, A D</creator><creator>Keung, C K</creator><creator>Yu, K-H</creator><creator>Mo, F K F</creator><creator>Bhatia, K S</creator><creator>Yeung, D K W</creator><creator>Tse, G M K</creator><creator>Vlantis, A C</creator><creator>Ahuja, A T</creator><general>American Society of Neuroradiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>201306</creationdate><title>T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma</title><author>King, A D ; Keung, C K ; Yu, K-H ; Mo, F K F ; Bhatia, K S ; Yeung, D K W ; Tse, G M K ; Vlantis, A C ; Ahuja, A T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - therapy</topic><topic>Chemoradiotherapy</topic><topic>Diffusion Magnetic Resonance Imaging - methods</topic><topic>Diffusion Magnetic Resonance Imaging - standards</topic><topic>Drug Monitoring - methods</topic><topic>Female</topic><topic>Head &amp; Neck</topic><topic>Head and Neck Neoplasms - pathology</topic><topic>Head and Neck Neoplasms - therapy</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm, Residual - pathology</topic><topic>Neoplasm, Residual - therapy</topic><topic>Nuclear polyhedrosis virus</topic><topic>Predictive Value of Tests</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Sensitivity and Specificity</topic><topic>Treatment Failure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>King, A D</creatorcontrib><creatorcontrib>Keung, C K</creatorcontrib><creatorcontrib>Yu, K-H</creatorcontrib><creatorcontrib>Mo, F K F</creatorcontrib><creatorcontrib>Bhatia, K S</creatorcontrib><creatorcontrib>Yeung, D K W</creatorcontrib><creatorcontrib>Tse, G M K</creatorcontrib><creatorcontrib>Vlantis, A C</creatorcontrib><creatorcontrib>Ahuja, A T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of neuroradiology : AJNR</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>King, A D</au><au>Keung, C K</au><au>Yu, K-H</au><au>Mo, F K F</au><au>Bhatia, K S</au><au>Yeung, D K W</au><au>Tse, G M K</au><au>Vlantis, A C</au><au>Ahuja, A T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma</atitle><jtitle>American journal of neuroradiology : AJNR</jtitle><addtitle>AJNR Am J Neuroradiol</addtitle><date>2013-06</date><risdate>2013</risdate><volume>34</volume><issue>6</issue><spage>1237</spage><epage>1241</epage><pages>1237-1241</pages><issn>0195-6108</issn><eissn>1936-959X</eissn><abstract>T2-weighted MRI shows potential in early posttreatment assessment of the primary tumor. Residual masses composed entirely of low T2-signal scar tissue suggest local control and those ≥1 cm of similar signal to untreated tumor suggest local failure. The purpose of this study was to investigate the diagnostic accuracy of T2-weighted MR imaging early after chemoradiotherapy for identifying primary tumor treatment failure in squamous cell carcinoma of the head and neck. At 6 weeks after treatment, T2-weighted MR images of 37 primary tumors in 37 patients were assessed. Residual masses were divided into 3 patterns: pattern 1 = scar tissue only (flat-edged/retracted mass of low T2 signal intensity); pattern 2 = mass without features described in pattern 1 or 3; and pattern 3 = any pattern that included an expansile mass ≥1 cm of intermediate T2 signal intensity (similar grade of signal intensity to the untreated tumor). T2 patterns were analyzed for local outcome (Fisher exact test) and time to local failure (univariate and multivariate analysis of T2 pattern, age, T stage, and tumor size by use of the Cox regression model). Residual masses after treatment were present in 34 (92%) of 37 patients. Local failures occurred in residual masses with pattern 1 in 0 (0%) of 14 patients; pattern 2 in 6 (55%) of 11 patients; and pattern 3 in 9 (100%) of 9 patients. Significant associations were found between local control and pattern 1 (P = &lt;.0001; sensitivity, 74%; specificity, 100%; PPV, 100%; NPV, 75%; accuracy, 85%), and between local failure and pattern 3 (P = &lt;.0001; sensitivity, 60%; specificity, 100%; PPV, 100%; NPV, 76%; accuracy, 82%). Pattern 2 showed no significant associations with local outcome. Univariate analysis of time to local failure showed that the T2 pattern was significant (P &lt; .0001) and remained significant on multivariate analysis. T2-weighted MR imaging is a potential tool for early posttreatment assessment of primary HNSCC treatment response. Awareness of correlation of the T2 pattern of any residual mass with treatment outcome at the primary site may contribute to patient treatment.</abstract><cop>United States</cop><pub>American Society of Neuroradiology</pub><pmid>23306012</pmid><doi>10.3174/ajnr.A3378</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0195-6108
ispartof American journal of neuroradiology : AJNR, 2013-06, Vol.34 (6), p.1237-1241
issn 0195-6108
1936-959X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7964595
source NCBI_PubMed Central(免费)
subjects Aged
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - therapy
Chemoradiotherapy
Diffusion Magnetic Resonance Imaging - methods
Diffusion Magnetic Resonance Imaging - standards
Drug Monitoring - methods
Female
Head & Neck
Head and Neck Neoplasms - pathology
Head and Neck Neoplasms - therapy
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm, Residual - pathology
Neoplasm, Residual - therapy
Nuclear polyhedrosis virus
Predictive Value of Tests
Reproducibility of Results
Retrospective Studies
Sensitivity and Specificity
Treatment Failure
title T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T14%3A16%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=T2-weighted%20MR%20imaging%20early%20after%20chemoradiotherapy%20to%20evaluate%20treatment%20response%20in%20head%20and%20neck%20squamous%20cell%20carcinoma&rft.jtitle=American%20journal%20of%20neuroradiology%20:%20AJNR&rft.au=King,%20A%20D&rft.date=2013-06&rft.volume=34&rft.issue=6&rft.spage=1237&rft.epage=1241&rft.pages=1237-1241&rft.issn=0195-6108&rft.eissn=1936-959X&rft_id=info:doi/10.3174/ajnr.A3378&rft_dat=%3Cproquest_pubme%3E1367877893%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1367877893&rft_id=info:pmid/23306012&rfr_iscdi=true